Dadun/></a>
				</td>
				<td class= Dadun
   (New user)
Help  | Contact  |  Castellano English  
 

Dadun > Depósito Académico > Clínica Universidad de Navarra > Cirugía general y digestiva > DA - CUN - Cirugía general y digestiva - Artículos de revista >

Risk factors for recurrence of hepatitis C after liver transplantation.
Authors: Herrero, J.I. (José Ignacio)
Peña, A. (Andrés) de la
Quiroga, J. (Jorge)
Sangro, B. (Bruno)
Garcia, N. (Nicolás)
Sola, J. (Josu)
Cienfuegos, J.A. (Javier A.)
Civeira, M.P. (María Pilar)
Prieto, J. (Jesús)
Keywords: Graft Rejection/pathology/prevention & control
Hepatitis C/enzymology/etiology/pathology
Immunosuppressive Agents/therapeutic use
Issue Date: 1998
Publisher: Wiley-Blackwell
Publisher version: http://onlinelibrary.wiley.com/doi/10.1002/lt.500040406/pdf
ISSN: 1527-6465
Citation: Herrero JI, de la Pena A, Quiroga J, Sangro B, Garcia N, Sola I, et al. Risk factors for recurrence of hepatitis C after liver transplantation. Liver Transpl Surg 1998 Jul;4(4):265-270.
Abstract
Recurrent hepatitis C is a frequent complication after liver transplantation for hepatitis C virus– related cirrhosis, but risk factors related to its development remain ill defined. Twenty-three patients receiving a primary liver graft for hepatitis C virus–related cirrhosis and with an assessable biopsy performed at least 6 months after liver transplantation were studied retrospectively. The end point of this study was to look for risk factors associated with the development of histologic hepatitis C in the graft. Thirty-six major variables were studied, and those reaching significance by univariate analysis were included in a multivariate analysis. Eighteen patients (78%) developed posttransplant hepatitis C. On univariate analysis, six variables showed significant predictive value: increased immunosuppression for treatment of acute rejection; pretransplant hepatocellular carcinoma; cumulative doses of prednisone at 3, 6, and 12 months after transplantation; and mean blood trough levels of cyclosporine in the first 6 months posttransplantation. On multivariate analysis, two variables retained independent statistical significance as predictors of hepatitis C recurrence, namely receipt of antirejection therapy (P 5 .0087) and lower mean cyclosporine levels in the first 6 months after transplantation (P 5 .0134). Therefore, recurrence of hepatitis C after liver transplantation seems to be at least partially related to posttransplantation immunosuppressive therapy.
Permanent link: http://hdl.handle.net/10171/23506
Appears in Collections:DA - CUN - Hepatología - Artículos de revista
DA - CUN - Cirugía general y digestiva - Artículos de revista

Files in This Item:
File:  Liver transpl 1998. 265.pdf
Description: 
Size:  238,46 kB
Format:  Adobe PDF
 View / Open 

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.